GLISITAPTIN 100

GLISITAPTIN 100 is an advanced oral anti-diabetic medicine containing Sitagliptin Phosphate 100 mg, a powerful DPP-4 inhibitor that helps improve glycemic control in adults with type 2 diabetes mellitus. Trusted by doctors, sitagliptin phosphate tablets are used either alone or in combination with other medications like metformin or sulfonylureas to lower blood sugar levels without causing hypoglycemia.

What is Sitagliptin Phosphate?

Sitagliptin phosphate is an oral antihyperglycemic agent that belongs to the class of drugs called DPP-4 (dipeptidyl peptidase-4) inhibitors. It works by increasing the levels of incretin hormones, which regulate insulin release and suppress glucagon secretion in a glucose-dependent manner. GLISITAPTIN 100 contains sitagliptin phosphate tablets IP 100 mg, formulated under strict pharmaceutical standards to ensure purity, potency, and long-lasting glycemic control.

Uses of Sitagliptin Phosphate Tablets

Here are the primary sitagliptin phosphate tablets uses:

• Control of Type 2 Diabetes Mellitus
  Helps lower elevated blood sugar levels in adults with type 2 diabetes, especially in combination with diet and exercise.

• Monotherapy or Combination Therapy
  Used as monotherapy or in combination with metformin, sulfonylureas, thiazolidinediones, or insulin.

• Improves Glycemic Control
  Maintains stable blood sugar without significant risk of hypoglycemia or weight gain.

• Cardiometabolic Protection (as per recent studies)
  Emerging data suggests potential cardiovascular safety in patients with type 2 diabetes.

Side Effects of Sitagliptin Phosphate Tablets

Most people tolerate GLISITAPTIN 100 well, but some may experience:

• Headache

• Nasopharyngitis (cold-like symptoms)

• Nausea or stomach discomfort

• Upper respiratory tract infection

• Diarrhea

• Joint pain (rare)

• Pancreatitis (very rare, but serious)

Stop the medication and consult your physician immediately if symptoms of allergic reaction, severe stomach pain, or difficulty breathing occur.

Precautions Before Using Sitagliptin Phosphate Tablets

Before starting GLISITAPTIN 100, inform your doctor if you:

• Have a history of pancreatitis

• Suffer from kidney impairment or are on dialysis

• Are pregnant or planning pregnancy

• Are breastfeeding

• Have a history of allergic reactions to sitagliptin or other DPP-4 inhibitors

What Drugs Interact with Sitagliptin Phosphate?   

Sitagliptin generally has low drug interaction potential, but inform your healthcare provider if you're using:

• Insulin or sulfonylureas – May increase risk of hypoglycemia

• Diuretics (e.g., furosemide) – May cause dehydration or impact kidney function

• ACE inhibitors – Combined use may increase risk of angioedema

• Corticosteroids – Can elevate blood sugar levels

• Digoxin – Sitagliptin may slightly increase digoxin levels

How to Purchase Sitagliptin Phosphate 100 mg Tablets from Steris Healthcare?

Purchasing Sitagliptin Phosphate 100 mg tablets from Steris Healthcare is simple, reliable, and customer-focused. As a trusted name in the Indian pharmaceutical industry, Steris Healthcare ensures that high-quality, GMP-certified diabetic medications like Sitagliptin are readily accessible to healthcare providers, distributors, and patients across India.

To place an order, you can directly connect with the Steris Healthcare sales or customer service team through their official website or contact details. The company offers seamless support for bulk orders, PCD pharma franchise inquiries, or hospital supply contracts. For individual buyers or pharmacy partners, Steris Healthcare provides fast shipping, transparent pricing, and genuine documentation with every order.

All products, including Sitagliptin Phosphate 100 mg, are manufactured under strict quality control standards and come with proper labeling, batch numbers, and expiry details. Whether you're a doctor seeking consistent supply for your patients, or a distributor looking for competitive diabetic care products, Steris Healthcare ensures prompt delivery and full regulatory compliance.